Emergent BioSolution Announces The FDA Has Initiated An Inspection Of The Bayview Facility; Co. Reports ' Emergent will not to initiate the manufacturing of any new material at its Bayview facility and to quarantine existing material manufactured at the Bayview facility pending completion of the inspection'